Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Blood Advances|September 11, 2020
Soluble glycoprotein VI is a predictor of major bleeding in patients with suspected heparin-induced thrombocytopeniaAllyson M Pishko, Robert K Andrews, Elizabeth E Gardiner, et al.Blood Advances|September 2, 2022
Adding caplacizumab to standard of care in thrombotic thrombocytopenic purpura: a systematic review and meta-analysisMia Djulbegovic, Jiayi Tong, Alice Xu, et al.Journal of Thrombosis and Thrombolysis|March 28, 2018
Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologistsAllyson M Pishko, Mudi Misgav, Adam Cuker, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 19, 2022
Cerebral Infarction due to Severe ADAMTS-13 Deficiency with Normal Hematological Parameters: A Cause of Cryptogenic StrokeAndrew Matthews, Jennifer Yui, Elaine Y Chiang, et al.Blood Advances|November 23, 2018
Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopeniaAllyson M Pishko, Sara Fardin, Daniel S Lefler, et al.Journal of Thrombosis and Haemostasis : JTH|May 24, 2023
A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?Leonard A Valentino, Margareth C Ozelo, Roland W Herzog, et al.ERJ Open Research|October 15, 2025
Evaluation of a screening protocol for telomere biology disorders in individuals with interstitial lung disease undergoing lung transplant evaluationDaisy Zhu, Namrata B Patel, Allyson M Pishko, et al.Blood|July 10, 2024
Enhanced procoagulant activity of select hemophilia B causing factor IX variants with emicizumabKyumin Lee, Julia Q Chau, Yani B Suber, et al.Journal of Thrombosis and Haemostasis : JTH|July 28, 2019
The risk of major bleeding in patients with suspected heparin-induced thrombocytopeniaAllyson M Pishko, Daniel S Lefler, Phyllis Gimotty, et al.British Journal of Haematology|December 8, 2025
Risk factors for silent cerebral infarction in immune-mediated thrombotic thrombocytopenic survivorsBinish Javed, Jia Yu, Jenna Brown, et al.Pageof 4